Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04227184Phase 4Completed
Phase 4, randomised, double-blind trial of trospium in urge incontinence (2 arms). Primary endpoint: Responder Status at 24 weeks. Started Feb 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04227184.